Insmed reported $78.35M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Cytokinetics USD 68.54M 54.6M Jun/2025
DBV Technologies USD 40.79M 6.65M Jun/2025
Dynavax Technologies USD 2.7M 1.63M Jun/2025
Gilead Sciences USD 582M 155M Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
Novartis USD 4.51B 66M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025